mifepristone and Small Cell Lung Carcinoma
mifepristone has been researched along with Small Cell Lung Carcinoma in 2 studies
Research
Studies (2)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Ray, DW; Singh, N; Sommer, P; Taylor, KM; Vosloo, D; Wheeler, R | 1 |
Mjoli, PB; Poolman, T; Ray, DW; Singh, N; Sommer, P; Taylor, K | 1 |
Other Studies
2 other study(ies) available for mifepristone and Small Cell Lung Carcinoma
Article | Year |
---|---|
The tobacco carcinogen NNK drives accumulation of DNMT1 at the GR promoter thereby reducing GR expression in untransformed lung fibroblasts.
Topics: Carcinogenesis; Carcinogens; Cell Line; DNA (Cytosine-5-)-Methyltransferase 1; DNA Methylation; Fibroblasts; Gene Expression Regulation, Neoplastic; Humans; Lung; Lung Neoplasms; Mifepristone; Nitrosamines; Promoter Regions, Genetic; Protein Binding; Receptors, Glucocorticoid; Small Cell Lung Carcinoma; Tobacco Smoking | 2018 |
The N-terminal transactivation domain of the glucocorticoid receptor mediates apoptosis of human small cell lung cancer cells.
Topics: Antimetabolites, Antineoplastic; Apoptosis; Azacitidine; Cell Line, Tumor; CpG Islands; Decitabine; DNA Methylation; Humans; Lung Neoplasms; Mifepristone; Promoter Regions, Genetic; Protein Structure, Tertiary; Receptors, Glucocorticoid; Small Cell Lung Carcinoma; Transcriptional Activation | 2014 |